AstraZeneca (AZN) is up 106.9%, or $99.16 to $191.93.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AZN:
- AstraZeneca Tests Next-Gen Cell Therapy in Multiple Sclerosis: What Investors Should Watch
- AstraZeneca’s Imfinzi perioperative regimen recommended for approval in EU
- AstraZeneca begins trading on New York Stock Exchange
- AstraZeneca Stock (AZN) Hits NYSE — Should US Investors Pay Attention?
- AstraZeneca Advances AZD5148: Early Safety Data Strengthens Its Infectious Disease Pipeline